Sarepta Therapeutics Inc

2026-11-11 21:06; UTC

Sarepta Therapeutics, Inc. is trading higher in Wednesday's session, recovering from an earlier decline while remaining below its 20-day moving average.

2026-11-10 21:02; UTC

Sarepta Therapeutics upgraded to Hold by Deutsche Bank, with the price target raised to $18 from $14, despite a significant decline in stock price today.

2026-11-09 23:06; UTC

Sarepta Therapeutics, Inc. shares advanced modestly in after-market hours, reaching a high that indicates a slight gain from Monday's close.

2026-11-06 21:03; UTC

RBC Capital raises Sarepta Therapeutics' price target to $18.00, citing strong Q3 results with adjusted EPS of $0.13 and revenue guidance increase of $50 million.

2026-11-05 23:31; UTC

Sarepta Therapeutics reported Q3 adjusted EPS of $0.13 and revenue of $381.4 million, but projected Q4 revenue at Q3 levels, raising investor concerns.

2026-11-04 21:07; UTC

Sarepta Therapeutics, Inc. shares are advancing as the broader market gains momentum, settling above its 20-day moving average and near the upper end of its one-month trading range.

2026-11-03 20:46; UTC

Sarepta Therapeutics, Inc. is trading higher, extending gains from Monday's close and remaining above its 20-day moving average despite a slight retracement.

2026-11-02 20:36; UTC

Sarepta Therapeutics, Inc. shares fell, continuing a three-session decline.

2026-10-30 23:51; UTC

Sarepta Therapeutics, Inc. is trading modestly higher in after-market hours after a strong upward movement from a low point shortly after the market closed.

2026-10-29 23:21; UTC

Sarepta Therapeutics, Inc. is trading lower in after-market hours, influenced by a broader market decline despite an earlier session rebound.

2026-10-28 19:46; UTC

Sarepta Therapeutics, Inc. is trading higher, reaching a peak cumulative return amid broader market strength and remaining above its 20-day moving average.

2026-10-27 23:21; UTC

Sarepta Therapeutics, Inc. shares declined in after-hours trading, reaching a low shortly after the market closed before a slight recovery.

2026-10-26 23:11; UTC

Sarepta Therapeutics Inc is declining in after-market trading, moving lower alongside the broader market after retracing from an earlier gain.

2026-10-23 20:07; UTC

Sarepta Therapeutics Inc shares fell amid broader market losses, influenced by rising oil prices, geopolitical tensions, and mixed economic indicators.

2026-10-22 20:07; UTC

Shares of Sarepta Therapeutics Inc are declining, following an early peak and midday drop.

2026-10-21 23:56; UTC

Sarepta Therapeutics Inc's shares are trading higher in after-market hours, following a day of fluctuating returns with prices ranging from a high of 0.48% to a low of -1.58%.

2026-10-20 20:01; UTC

Sarepta Therapeutics Inc is advancing, continuing its upward trend with gains since Monday's close, despite an earlier pullback from a session high.

2026-10-16 20:07; UTC

Sarepta Therapeutics Inc shares are declining, continuing a downward trend from Thursday's close, despite new data suggesting safe administration of Elevidys to younger boys.

2026-10-15 20:02; UTC

Sarepta Therapeutics presents new preclinical data on SRP-1003 at the Oligonucleotide Therapeutics Society meeting, showing promise for treating myotonic dystrophy type 1.

2026-10-14 20:07; UTC

Sarepta Therapeutics presented new preclinical data showing SRP-1003 achieved approximately 80% knockdown of pathogenic DMPK RNA, advancing treatment for myotonic dystrophy type 1.

2026-10-13 20:01; UTC

Sarepta Therapeutics Inc shares fell sharply, continuing a notable decline that has kept the stock well below its 20-day moving average.

2026-10-12 23:11; UTC

Sarepta Therapeutics Inc shares are trading modestly higher in after-market hours, following a period of notable decline and unusual trading behavior since Monday's close.

2026-10-09 20:07; UTC

Sarepta Therapeutics shares fell sharply, reaching a low mid-morning, amid broader market declines following a drop in the Michigan Consumer Sentiment Index to 46.3.

2026-10-08 20:06; UTC

Sarepta Therapeutics Inc shares are advancing as the broader market rebounds, with cumulative returns exceeding 4% since Wednesday.

2026-10-06 19:15; UTC

Sarepta Therapeutics Inc shares fell sharply, moving from an early gain to a significant decline and remaining below the 20-day moving average.

2026-10-05 23:40; UTC

Sarepta Therapeutics Inc is trading modestly lower in after-market hours, continuing a trend of declines over the last five sessions amid broader biotechnology sector weakness.

2026-10-02 19:35; UTC

Sarepta Therapeutics Inc shares fell, marking a fifth consecutive session of lower closes, amid broader market weakness contributing to a significant monthly decline.

2026-10-01 23:30; UTC

Sarepta Therapeutics Inc. advanced in after-market trading, gaining ground after Thursday's close, despite being below its 20-day moving average.

2026-09-30 23:30; UTC

Sarepta Therapeutics shares are trading higher in after-market hours following new data on ELEVIDYS presented at the World Muscle Society Congress.

2026-09-29 19:15; UTC

Sarepta Therapeutics Inc shares fell sharply, currently trading significantly below its 20-day moving average and near the lower end of its one-month range.